Table 3.
Parameters | Cohort A (n = 131) | Cohort B (n = 120) | ||
---|---|---|---|---|
Rho | P value | Rho | P value | |
Parameters for liver injury | ||||
ALT | 0.262 | 0.003 | 0.258 | 0.004 |
AST | 0.526 | <0.001 | 0.278 | 0.002 |
GGT | 0.557 | <0.001 | 0.186 | 0.041 |
TBA | 0.378 | <0.001 | 0.180 | 0.049 |
Necroinflammation activity grade (G) | 0.364 | <0.001 | 0.297 | 0.001 |
Parameters for liver fibrosis | ||||
PLT | -0.373 | <0.001 | -0.392 | <0.001 |
Fibrosis stage (F) | 0.484 | <0.001 | 0.269 | 0.003 |
APRI | 0.584 | <0.001 | 0.345 | <0.001 |
FIB-4 | 0.580 | <0.001 | 0.380 | <0.001 |
Parameters for liver function | ||||
TBIL | 0.136 | 0.122 | 0.009 | 0.924 |
ALB | -0.431 | <0.001 | -0.389 | <0.001 |
PT | 0.374 | <0.001 | 0.228 | 0.012 |
PA | -0.537 | <0.001 | -0.464 | <0.001 |
GP73: Golgi protein 73; ALT: alanine aminotransferase; AST: aspartate aminotransferase; GGT: gamma glutamyltransferase; TBA: total bile acid; PLT: platelet; APRI: AST-to-platelet ratio index; FIB-4: fibrosis index based on four factors; TBIL: total bilirubin; ALB: albumin; PT: prothrombin time; PA: prealbumin.